AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 82 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $31,000 | -48.3% | 21,236 | -8.8% | 0.00% | – |
| Q4 2018 | $60,000 | -41.2% | 23,291 | 0.0% | 0.00% | – |
| Q3 2018 | $102,000 | -28.7% | 23,291 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $143,000 | -15.9% | 23,291 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $170,000 | -11.0% | 23,291 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $191,000 | -22.0% | 23,291 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $245,000 | +26.3% | 23,291 | +32.7% | 0.00% | 0.0% |
| Q2 2017 | $194,000 | – | 17,555 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,625,000 | $12,269,000 | 3.04% |
| GENDELL JEFFREY L | 1,146,764 | $8,658,000 | 1.11% |
| Broadfin Capital, LLC | 1,029,012 | $7,769,000 | 1.04% |
| RTW INVESTMENTS, LP | 3,401,434 | $25,681,000 | 0.97% |
| BRANDES INVESTMENT PARTNERS, LP | 3,651,948 | $27,571,000 | 0.66% |
| Aristides Capital LLC | 71,520 | $540,000 | 0.42% |
| Tekla Capital Management LLC | 814,588 | $6,150,000 | 0.23% |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 36,100 | $273,000 | 0.17% |
| Leap Investments LP | 43,481 | $328,000 | 0.15% |
| Brown Capital Management | 1,829,886 | $13,816,000 | 0.13% |